FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/06/2026
Back to search
Official data from USPTO
SYGNATURE DISCOVERY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SYGNATURE DISCOVERY
ST13
US500000079410216Class
1, 40, 42
Filing
79410216
Registration
8097762
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
08/06/2026
Trademark type
Word
Nice classes
1, 40, 42
Filing date
09/12/2024
Registration date
01/13/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/13/2026
Last transaction
08/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
MARSH, LAURA KATHLEEN
Law office
L70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Sygnature Discovery Limited
Representatives
Molly T. Eichten Larkin Hoffman Daly & Lindgren Ltd.
Technical classification
Nice Classes
Class 1Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Proteins for industrial use; proteins for use in manufacture; proteins for use in scientific research; proteins for use in the manufacture of pharmaceutical products; protein in raw material form for material scienceagritechcosmeceutical research; protein in raw material form for industrial use; protein in raw material form for use in manufacture; protein in raw material form for use in scientific research; protein in raw material form for use in the manufacture of pharmaceutical products.
Class 40
Processing of organic chemical liquids in the nature of chemical distillery services; recycling of organic solvents; purification of proteins; purification of proteins by chemical methods.
Class 42
Scientific research and development services; drug discovery services; development of pharmaceutical preparations and medicines; drug screening for scientific research purposes; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of human and veterinary pharmaceutical drugs; research relating to medicines; services for assessing the efficacy of human and veterinary pharmaceutical drugshuman and veterinary pharmaceutical product evaluationhuman and veterinary pharmaceutical drug discovery services; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and developments; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and drug development; research and development in the pharmaceutical and drug development fields; testing of pharmaceutical drugs; assay development services being custom design and development of biophysicalbiochemicalcell-basedphenotypicin-vitro and in-vivoassays; biological research; biological analysis; biological research laboratory services; biological researchclinical research in the field of immunotherapycancerous diseasesrespiratory diseasesneurosciencefibrotic diseasesmetabolic diseases and infectious diseases and medical research; consultancy relating to pharmacology; medical and pharmacological research services; scientific research for medical purposes in the field of immunotherapycancerous diseasesrespiratory diseasesneurosciencefibrotic diseasesmetabolic diseases and infectious diseases; research in the field of synthetic biology; research and development in the field of microorganisms and cells; chemical research and analysis services; chemical engineering; chemistry serviceslaboratory research in the field of chemistry; medicinalsyntheticanalytical and high throughput chemistry serviceshit generation and optimizationlead optimisationscale up manufacturemetaboliteanalogueimpurityanalytical standard synthesis and/or isolation and purificationstructure elucidation; clinical research in the field of immunotherapycancerous diseasesrespiratory diseasesneurosciencefibrotic diseasesmetabolic diseases and infectious diseases; organic chemistry research and analysis services; consultancy in the field of organic chemistry; laboratory research and analysis services in the field of organic chemistry; research and development services in the field of organic chemistry; developmenttesting and analysis of chemicals; developmenttesting and analysis of chemical production methods; protein and peptide mapping for scientific purposes; scientific analysis servicesscientific analysis of materials for human and veterinary pharmaceuticalmaterial scienceagritechcosmeceutical research for scientific research purposes; protein analysis services for scientific purposes; scientific research in the field of protein sequencing; protein crystallisation screening for scientific purposes; quality control for others; testing of materials; product testing; technological research in the field of immunotherapycancerous diseasesrespiratory diseasesneurosciencefibrotic diseasesmetabolic diseases and infectious diseases; industrial analysis and research services in the field of immunotherapycancerous diseasesrespiratory diseasesneurosciencefibrotic diseasesmetabolic diseases and infectious diseases; scientific services relating to cell line generation; scientific screening services being ion channel screeningiterative screeningfragment screening and in silico screeningfor scientific research purposes; compound profiling and selectivity services; X-ray and cryoelectronmicroscopy imaging and NMR structure determination of proteinsbiological macromolecules and moleculesother than for medical purposes; blood analysis services for scientific research purposes; informationadvisory and consultancy services relating to the aforesaid services.
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/18/2026
FIMP
FINAL DISPOSITION PROCESSED
07/18/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/07/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/20/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/20/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/13/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/13/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
01/13/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/25/2025
PUBO
PUBLISHED FOR OPPOSITION
11/25/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/19/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/27/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/24/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/24/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/24/2025
RFNT
REFUSAL PROCESSED BY IB
05/09/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/24/2025
RFRR
REFUSAL PROCESSED BY MPU
04/24/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/14/2025
CNRT
NON-FINAL ACTION WRITTEN
03/13/2025
DOCK
ASSIGNED TO EXAMINER
03/12/2025
MAFR
APPLICATION FILING RECEIPT MAILED
11/25/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/25/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/21/2024
Continuous trademark protection
Get notified about every new filing that threatens SYGNATURE DISCOVERY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.